A prospective cohort study of patients with non-squamous non-small cell lung cancer treated with bevacizumab

First-line chemotherapy regimens that include bevacizumab (Bev) have been hypothesized to improve outcomes in patients with advanced non-squamous non-small cell lung cancer (non-sq NSCLC). Although approved to treat NSCLC in 2009, insufficient data exist on the clinical uses of Bev in Japan. The pre...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncol Lett
Main Authors: Naoki, Katsuhiko, Takeda, Yuichiro, Soejima, Kenzo, Arai, Daisuke, Naka, Go, Nagase, Seisuke, Arimura, Ken, Kanemura, Toshinori, Ohhira, Tatsuo, Ikeda, Norihiko
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2017
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5431393/
https://ncbi.nlm.nih.gov/pubmed/28521435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5796
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki